证券代码：600844，900921 证券简称：金煤科技，金煤 B 股 编号：临 2025－039 内蒙古金煤化工科技股份有限公司 关于 2024 年度向特定对象发行 A 股股票申请 获得上海证券交易所受理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 公司于 2025 年 8 月 29 日收到上海证券交易所（以下简称"上交所"）出具 的《关于受理内蒙古金煤化工科技股份有限公司沪市主板上市公司发行证券申请 的通知》【上证上审（再融资）〔2025〕261 号】，上交所依据相关规定对公司报 送的沪市主板上市公司发行证券的募集说明书及相关申请文件进行了核对，认为 申请文件齐备，符合法定形式，决定予以受理并依法进行审核。 公司 2024 年度向特定对象发行 A 股股票事项尚需经上交所审核通过，并获 得中国证券监督管理委员会（以下简称"中国证监会"）作出同意注册的决定后 方可实施，最终能否通过上交所审核并获得中国证监会同意注册的决定尚存在不 确定性。公司将根据进展情况，按照相关法律法规要求及时履行信息披露义务， 敬请广大投 ...

Core Viewpoint - Inner Mongolia Jinmei Chemical Technology Co., Ltd. has issued a correction announcement regarding its 2025 semi-annual report, identifying several errors that need to be amended in the report [1][4]. Group 1: Shareholder Information - The correction includes changes to the list of the top ten shareholders and their respective shareholdings, with notable adjustments in the number of shares held by certain shareholders [1]. - The corrected data shows that the asset management plan under the name "Caitong Fund - Industrial and Commercial Bank - Fuchun Private Placement" now holds 25,631,400 shares, a significant increase from the previously reported figure [1]. Group 2: Financial Report Adjustments - The correction also affects the financial report, specifically the section on other receivables, where the ending balance for "borrowings" has been updated to 130,623.43 yuan, reflecting a change from the previous figure [2]. - The total balance for "other receivables" remains unchanged at 122,050,594.63 yuan, indicating that the overall financial position is consistent despite the individual line item adjustments [2][3]. Group 3: Long-term Equity Investments - The report includes corrections to the long-term equity investment section, with the initial balance for joint ventures and associates remaining at 524,829.97 yuan, confirming no changes in the overall investment value [4]. - The adjustments do not affect the financial statements significantly, as the company states that the corrections do not involve any adjustments to the financial reports [4].

Group 1 - The company plans to raise a total of no more than 564.51 million yuan through a private placement of shares, with all proceeds intended to supplement working capital [1] - The necessity of the fundraising is highlighted by the company's recent poor performance due to low product prices and rising raw material costs, necessitating additional working capital to alleviate financial pressure [2][3] - The company aims to enhance production efficiency, improve product structure, and strengthen partnerships with third parties through the raised funds [2] Group 2 - As of June 30, 2025, the company has total liabilities of 913.28 million yuan, with current liabilities at 859.29 million yuan, indicating significant operational pressure [3] - The controlling shareholder, Jin Rui Hong Ji, acquired a 15% stake in the company, which will stabilize control and governance post-fundraising [3][4] - The fundraising is compliant with relevant laws and regulations, ensuring its feasibility and alignment with corporate governance standards [5] Group 3 - The issuance of shares is expected to improve the company's capital structure, reduce financial risks, and enhance operational capabilities [5][6] - The influx of funds will significantly increase the company's liquidity, facilitating business operations and equipment upgrades [6] - Overall, the fundraising initiative aligns with the company's strategic development plans and is expected to promote sustainable growth and shareholder interests [6]

Group 1 - The company plans to issue up to 303.5 million shares to raise no more than 564.51 million yuan to alleviate operational funding pressure and improve financial conditions [1][8][25] - The issuance aims to enhance the company's risk resistance and sustainable operation capabilities, focusing on the coal chemical industry and sustainable development [1][2][25] - The company has faced operational challenges due to low product prices and rising raw material costs, necessitating this capital raise to support strategic goals [7][8][25] Group 2 - The company operates primarily through its subsidiary, Tongliao Jinmei Chemical Co., which specializes in coal-to-ethylene glycol production [2][5] - The coal chemical industry is seen as a vital solution to China's energy structure issues, promoting the efficient use of coal and reducing reliance on oil [2][4] - The company has developed significant technology in coal-to-ethylene glycol production, positioning itself as a pioneer in this field [5][6] Group 3 - The issuance will allow the company to adjust production based on market performance of its main products, ethylene glycol and oxalic acid, enhancing market responsiveness [8][25] - The company aims to invest in technological upgrades and product research and development to improve production efficiency and expand its product range [8][25] - The company’s main products, ethylene glycol and oxalic acid, have significant market demand, particularly in the renewable energy sector and electronic ceramics [6][7][8] Group 4 - The issuance will be directed to the company's controlling shareholder, Jinrui Hongji, which will consolidate control and stabilize governance [9][10][25] - The issuance price is set at 1.86 yuan per share, based on the average trading price over the previous 20 trading days [12][13] - The company has committed to using the raised funds strictly for operational needs, ensuring compliance with regulatory requirements [22][25]

Group 1 - The core point of the article is that Jinmei Technology (SH 600844) announced the convening of its 11th Board of Directors meeting to review the feasibility analysis report for raising funds through a specific issuance of A-shares for the year 2024 [1] - For the first half of 2025, Jinmei Technology's revenue composition shows that the chemical sector accounts for 98.96%, while other businesses contribute 1.04% [1] - As of the report, Jinmei Technology has a market capitalization of 3.4 billion yuan [1] Group 2 - The A-share market has seen trading volumes exceed 2 trillion yuan for eight consecutive days, indicating strong market activity [1] - Major brokerage firms are actively recruiting for autumn positions, highlighting a demand for talent in the industry [1]

证券代码：600844，900921 证券简称：金煤科技，金煤 B 股 编号：临 2025－038 内蒙古金煤化工科技股份有限公司 关于 2025 年半年度报告的更正公告 1 | 号资产管理计划 | | | | | --- | --- | --- | --- | | 李利伟 | 20,000,000 | 人民币普通股 | 20,000,000 | | 吉林丰成顺农业有限公司 | 14,903,266 | 人民币普通股 | 14,903,266 | | 张大龙 | 10,550,000 | 人民币普通股 | 10,550,000 | | 北京顶尖私行资本管理有限公司 | 10,000,000 | 人民币普通股 | 10,000,000 | | 江苏丹化煤制化学品工程技术有限公 | 8,050,600 | 人民币普通股 | 8,050,600 | | 司 | | | | | 丹阳市丹化运输有限公司 | 7,675,782 | 人民币普通股 | 7,675,782 | | 徐前 | 5,500,000 | 人民币普通股 | 5,500,000 | 二、"第八节-财务报告，七、合并财务报表项目注释，9、其他应收款，其 ...

内蒙古金煤化工科技股份有限公司 2024 年度向特定对象发行 A 股股票方案的 论证分析报告 （2025 年 8 月修订） 内蒙古金煤化工科技股份有限公司（以下简称"公司"）是上海证券交易所（以 下简称"上交所"）主板上市公司。为缓解公司营运资金需求压力，改善公司财务 状况，提升公司抗风险能力，增强公司持续经营能力，根据《中华人民共和国公 司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司证券发行注册管理办法》（以下简称为"《注册管理办法》"）等有关法 律、法规和规范性文件的规定，公司拟向特定对象发行股票，发行股票数量预计 不超过 30,350.00 万股（含本数），拟募集资金不超过 56,451.00 万元（含本数）， 扣除发行费用后将全额用于补充流动资金。 （本论证分析报告中如无特别说明，相关用语与《丹化化工科技股份有限公 司 2024 年度向特定对象发行 A 股股票预案》中的含义相同。） 一、本次向特定对象发行股票的背景和目的 （一）本次向特定对象发行股票的背景 公司始终聚焦煤化工领域，以可持续发展为导向，实施做大做强战略；依托 对各方产业资源和技术优势的 ...

二〇二五年八月（修订） 2024 年度向特定对象发行 A 股股票 募集资金使用可行性分析报告 1 1、充实营运资金，拓展融资路径，促进公司可持续健康发展 为缓解内蒙古金煤化工科技股份有限公司（以下简称"公司"）的营运资金 需求压力，提高偿债能力，改善公司财务状况，提升公司抗风险能力，增强公 司持续经营能力，公司向特定对象发行股票募集资金将全额用于补充公司流动 资金。对于本次募集资金使用的可行性分析如下： 公司具有成熟的煤制乙二醇、草酸等相关产品的生产制备技术，在煤化工 领域具有较强的技术能力。近年来，由于主要产品价格低迷、褐煤等原料价格 上涨等不利因素，公司的经营业绩表现较差，连年亏损。公司需要充实营运资 金，缓解公司资金压力，为公司实现经营战略目标提供资金保障。 另一方面，受制于近年来业绩表现较差，公司的融资渠道受限，同第三方 开展业务合作同样亦会受到影响，公司亟需以股权融资方式补充资金，壮大公 司资本实力，帮助公司跨越难关，以满足公司提升现有的生产效率，改善产品 结构，进一步增强与第三方合作等方面的发展需求。 一、本次向特定对象发行募集资金使用计划 公司本次向特定对象发行股票募集资金全额用于补充公司流动资 ...

证券代码：600844，900921 证券简称：金煤科技，金煤 B 股 编号：临 2025－037 内蒙古金煤化工科技股份有限公司 十一届十五次董事会决议公告 修订后的《论证分析报告》和《可行性分析报告》将与本公告一起在上海证 券交易所网站（www.sse.com.cn）同日披露。 表决结果：9 票赞成，0 票反对，0 票弃权。 1 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 公司第十一届董事会第十五次会议通知于 2025 年 8 月 19 日以微信及电子邮 件方式发出，会议由董事长蒋涛召集，于 2025 年 8 月 22 日以通讯方式召开，应 表决董事 9 名，实际参加表决董事 9 名。本次会议的召开符合《公司法》和《公 司章程》的有关规定。 会议审议并通过了如下议案： 一、关于《2024 年度向特定对象发行 A 股股票方案的论证分析报告（修订）》 的议案 二、关于《2024 年度向特定对象发行 A 股股票募集资金使用可行性分析报 告（修订）》的议案 2024 年 7 月 19 日，公司十一届四次董事会会议审议通过 ...

5.7.5 Meta Biomed企业最新动态 5.8 丹化科技 5.8.1 丹化科技基本信息、聚乙交酯（PGA）生产基地、销售区域、竞争对手及市场地位 5.8.2 丹化科技 聚乙交酯（PGA）产品规格、参数及市场应用 5.8.3 丹化科技 聚乙交酯（PGA）销量、收入、价格及毛利率（2020-2025） 5.8.4 丹化科技公司简介及主要业务 5.8.5 丹化科技企业最新动态 5.9 惠州华阳医疗 5.9.1 惠州华阳医疗基本信息、聚乙交酯（PGA）生产基地、销售区域、竞争对手及市场地位 5.9.2 惠州华阳医疗 聚乙交酯（PGA）产品规格、参数及市场应用 5.9.3 惠州华阳医疗 聚乙交酯（PGA）销量、收入、价格及毛利率（2020-2025） 5.9.4 惠州华阳医疗公司简介及主要业务 5.9.5 惠州华阳医疗企业最新动态 5.10 上海浦景化工 5.10.1 上海浦景化工基本信息、聚乙交酯（PGA）生产基地、销售区域、竞争对手及市场地位 5.10.2 上海浦景化工 聚乙交酯（PGA）产品规格、参数及市场应用 5.10.3 上海浦景化工 聚乙交酯（PGA）销量、收入、价格及毛利率（2020-2025） ...